MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings. The new ...

The best bike boxes make it easy to transport your pride and joy abroad while giving you peace of mind that it shouldn’t get damaged in transit. There are a huge number of solutions available for ...

Embarking on a triathlon can feel daunting. With three disciplines to train in as well as transitions to practise, it can be tricky to know how to balance your training. Not only that, but you need to ...